PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Secukinumab - Hidradenitis suppurativa
PAD Profile : Secukinumab - Hidradenitis suppurativa
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
- Psoriasis
- Ankylosing spondylitis
- Psoriatic arthritis
- Any paediatric use
- Non-radiographic axial spondyloarthritis
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
19 September 2023
Not Set
This drug falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication
Associated BNF Codes
13. Skin
13.05.03. Drugs affecting the immune response